On the other hand, there are few reports on the efficacy of radical local therapy in patients with recurrent NSCLC who are positive for EGFR mutations, as EGFR‐TKIs enable long‐term survival in this patient group. Here, EGFR is linked to non-small cell lung carcinoma.